CoChat
Sign Up
Cited by 32

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry

Reimund, Mart, Kovrov, Oleg, Olivecrona, Gunilla, Lookene, Aivar·2017·Journal of Lipid Research
DOI 10.1194/jlr.d071787
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.d071787

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. Olivecrona, 2016, Role of lipoprotein lipase in lipid metabolism, Curr. Opin. Lipidol., 27, 233, 10.1097/MOL.0000000000000297 · DOI
  2. Young, 2013, Biochemistry and pathophysiology of intravascular and intracellular lipolysis, Genes Dev., 27, 459, 10.1101/gad.209296.112 · DOI
  3. Musunuru, 2016, Surprises from genetic analyses of lipid risk factors for atherosclerosis, Circ. Res., 118, 579, 10.1161/CIRCRESAHA.115.306398 · DOI · Paper page
  4. Khetarpal, 2015, Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics, Arterioscler. Thromb. Vasc. Biol., 35, e3, 10.1161/ATVBAHA.114.305172 · DOI
  5. Rader, 2016, New therapeutic approaches to the treatment of dyslipidemia, Cell Metab., 23, 405, 10.1016/j.cmet.2016.01.005 · DOI
  6. Dallinga-Thie, 2016, Triglyceride-rich lipoproteins and remnants: targets for therapy?, Curr. Cardiol. Rep., 18, 67, 10.1007/s11886-016-0745-6 · DOI · Paper page
  7. Davies, 2010, GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries, Cell Metab., 12, 42, 10.1016/j.cmet.2010.04.016 · DOI · Paper page
  8. Dijk, 2016, Regulation of lipid metabolism by angiopoietin-like proteins, Curr. Opin. Lipidol., 27, 249, 10.1097/MOL.0000000000000290 · DOI
  9. Karpe, 1992, Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids, J. Lipid Res., 33, 975, 10.1016/S0022-2275(20)41413-0 · DOI · Paper page
  10. Eisenberg, 1979, Very low density lipoprotein. Fate of phospholipids, cholesterol, and apolipoprotein C during lipolysis in vitro, J. Lipid Res., 20, 614, 10.1016/S0022-2275(20)40584-X · DOI
  11. Robal, 2012, Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase, J. Biol. Chem., 287, 29739, 10.1074/jbc.M111.303529 · DOI · Paper page
  12. Peterson, 1990, Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport, Proc. Natl. Acad. Sci. USA., 87, 909, 10.1073/pnas.87.3.909 · DOI · Paper page
  13. Olivecrona, 1997, Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons, Arterioscler. Thromb. Vasc. Biol., 17, 1545, 10.1161/01.ATV.17.8.1545 · DOI
  14. Lookene, 2004, Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer, J. Biol. Chem., 279, 49964, 10.1074/jbc.M407419200 · DOI
  15. Lookene, 1993, Chymotryptic cleavage of lipoprotein lipase. Identification of cleavage sites and functional studies of the truncated molecule, Eur. J. Biochem., 213, 185, 10.1111/j.1432-1033.1993.tb17747.x · DOI
  16. Bengtsson-Olivecrona, 1991, Phospholipase activity of milk lipoprotein lipase, Methods Enzymol., 197, 345, 10.1016/0076-6879(91)97160-Z · DOI
  17. Bengtsson-Olivecrona, 1990, Primary structure of the bovine analogues to human apolipoproteins CII and CIII. Studies on isoforms and evidence for proteolytic processing, Eur. J. Biochem., 192, 515, 10.1111/j.1432-1033.1990.tb19255.x · DOI
  18. Shen, 2010, Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase, J. Biol. Chem., 285, 7484, 10.1074/jbc.M109.022046 · DOI
  19. Beckstead, 2003, Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis, Biochemistry., 42, 9416, 10.1021/bi034509t · DOI
  20. Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 · DOI
  21. Perret, 2002, Hepatic lipase: structure/function relationship, synthesis, and regulation, J. Lipid Res., 43, 1163, 10.1194/jlr.R100020-JLR200 · DOI
  22. Kei, 2012, A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease, Metabolism., 61, 906, 10.1016/j.metabol.2011.12.002 · DOI · Paper page
  23. Quinn, 1983, Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism, Prog. Lipid Res., 22, 35, 10.1016/0163-7827(83)90003-6 · DOI
  24. Bengtsson, 1980, Lipoprotein lipase: some effects of activator proteins, Eur. J. Biochem., 106, 549, 10.1111/j.1432-1033.1980.tb04602.x · DOI
  25. Fredenrich, 1997, Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions, J. Lipid Res., 38, 1421, 10.1016/S0022-2275(20)37424-1 · DOI
  26. Nilsson, 2011, Apolipoprotein A-V; a potent triglyceride reducer, Atherosclerosis., 219, 15, 10.1016/j.atherosclerosis.2011.07.019 · DOI
  27. O'Brien, 2005, The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins, Clin. Chem., 51, 351, 10.1373/clinchem.2004.040824 · DOI
  28. Robciuc, 2010, Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample, J. Lipid Res., 51, 824, 10.1194/jlr.M002618 · DOI
  29. Sonnenburg, 2009, GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4, J. Lipid Res., 50, 2421, 10.1194/jlr.M900145-JLR200 · DOI · Paper page
  30. Reimund, 2015, Evidence for two distinct binding sites for lipoprotein lipase on glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), J. Biol. Chem., 290, 13919, 10.1074/jbc.M114.634626 · DOI
  31. Mysling, 2016, The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain, eLife., 5, e12095, 10.7554/eLife.12095 · DOI
  32. McCoy, 2002, Characterization of the lipolytic activity of endothelial lipase, J. Lipid Res., 43, 921, 10.1016/S0022-2275(20)30466-1 · DOI · Paper page
  33. Badellino, 2006, Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis, PLoS Med., 3, e22, 10.1371/journal.pmed.0030022 · DOI
  34. Briquet-Laugier, 1999, Determining lipoprotein lipase and hepatic lipase activity using radiolabeled substrates, Methods Mol. Biol., 109, 81
  35. Panteghini, 2001, Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate, Ann. Clin. Biochem., 38, 365, 10.1258/0004563011900876 · DOI
  36. Basu, 2011, Determination of lipoprotein lipase activity using a novel fluorescent lipase assay, J. Lipid Res., 52, 826, 10.1194/jlr.D010744 · DOI
  37. Di Filippo, 2014, Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects, PLoS One., 9, e99721, 10.1371/journal.pone.0096482 · DOI
  38. Dole, 1956, A relation between non-esterified fatty acids in plasma and the metabolism of glucose, J. Clin. Invest., 35, 150, 10.1172/JCI103259 · DOI
  39. Pennacchio, 2001, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing, Science., 294, 169, 10.1126/science.1064852 · DOI · Paper page
  40. Sharma, 2013, Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol, Curr. Opin. Lipidol., 24, 153, 10.1097/MOL.0b013e32835c8c1a · DOI
  41. Lookene, 2005, Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism, J. Biol. Chem., 280, 25383, 10.1074/jbc.M501589200 · DOI
  42. Larsson, 2013, Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets, J. Biol. Chem., 288, 33997, 10.1074/jbc.M113.495366 · DOI
  43. Gibson, 1987, Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia, Arteriosclerosis., 7, 401, 10.1161/01.ATV.7.4.401 · DOI
  44. Sukonina, 2006, Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue, Proc. Natl. Acad. Sci. USA., 103, 17450, 10.1073/pnas.0604026103 · DOI · Paper page
  45. Yau, 2009, A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization, J. Biol. Chem., 284, 11942, 10.1074/jbc.M809802200 · DOI · Paper page
  46. Chi, 2015, Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1, J. Biol. Chem., 290, 11865, 10.1074/jbc.M114.623769 · DOI · Paper page
  47. Shan, 2009, The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms, J. Biol. Chem., 284, 1419, 10.1074/jbc.M808477200 · DOI · Paper page
  48. Lafferty, 2013, Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation, J. Biol. Chem., 288, 28524, 10.1074/jbc.M113.497602 · DOI · Paper page
  49. Nilsson, 2012, Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4, Biochim. Biophys. Acta., 1821, 1370, 10.1016/j.bbalip.2012.06.003 · DOI · Paper page
  50. Gusarova, 2015, ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys, J. Lipid Res., 56, 1308, 10.1194/jlr.M054890 · DOI · Paper page
  51. Larsson, 2014, Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo, Biochem. Biophys. Res. Commun., 450, 1063, 10.1016/j.bbrc.2014.06.114 · DOI
  52. Amar, 2015, A novel apolipoprotein C–II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice, J. Pharmacol. Exp. Ther., 352, 227, 10.1124/jpet.114.220418 · DOI
  53. Sakurai, 2016, Creation of apolipoprotein C-II (apoC-II) mutant mice and correction of their hypertriglyceridemia with an apoC-II mimetic peptide, J. Pharmacol. Exp. Ther., 356, 341, 10.1124/jpet.115.229740 · DOI

Cited by

Sorted by citations

See all 32

Metadata

Authors
Reimund, M., Kovrov, O., Olivecrona, G., & Lookene, A.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2017-01
Volume
58
Issue
1
Pages
279-288
ISSN
0022-2275
DOI
10.1194/jlr.d071787
Cited by
32
References
7
Language
en
Licence
Funders
Swedish Research Council for Health, Working Life and Welfare (12203)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review